Overview
- 14 inspections across 14 sites are on record.
- 29 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-04-04.
At a glance
Inspections
14
Sites
14
Observations
29
Career since
Jun 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Similasan AG | 4 Apr 2023 | Human Drugs | On file |
| Ivers-Lee SA | 22 Mar 2023 | Human Drugs | On file |
| Fermion OY | 17 Mar 2023 | Human Drugs | On file |
| Eugia Pharma Specialities Limited | 13 Nov 2019 | Medical Devices & Rad Health | On file |
| Kopalle Pharma Chemical Pvt Ltd. | 13 Oct 2017 | Human Drugs | On file |
Sites inspected
Similasan AGJonen, Switzerland1 insp.
Ivers-Lee SABurgdorf, Switzerland1 insp.
Fermion OYHanko Pohjoinen, Finland1 insp.
Eugia Pharma Specialities LimitedSangareddy, India1 insp.
Kopalle Pharma Chemical Pvt Ltd.Hyderabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Lisa Shin3 shared
David A Oluwo3 shared
Michele Perry-Williams3 shared
Virgilio F Pacio3 shared
Lisa B Orr2 shared
Marvin D Jones2 shared
Marie B Buen-Bigornia1 shared
Thomas J Arista1 shared
June P Page1 shared
Dipesh K Shah1 shared
Full investigator report
Get the verbatim findings behind Freddy Ortiz Colon's 29 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site